JAKMIP2-AS1

Across TCGA pan-cancer cohorts, JAKMIP2-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated JAKMIP2-AS1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher JAKMIP2-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated JAKMIP2-AS1 expression acts as an unfavorable survival marker, although some lineages such as PAAD and LUAD show a favorable association.

MESO, DLBC, and KIRC are the cancer types where JAKMIP2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Quartile	All	0.251	0.497	<.001	86	view →
DLBC	OS	Quartile	All	0.389	0.881	<.001	79	view →
KIRC	OS	Quartile	All	0.517	0.660	.002	59	view →
STAD	DFS	Median	II,III,IV	0.537	0.768	.003	36	view →
CHOL	OS	Tertile	All	0.183	0.846	<.001	31	view →
UCS	OS	Tertile	III,IV	0.340	0.733	.016	30	view →
PAAD	DFS	Median	All	0.409	0.205	.002	29	view →
LUAD	OS	Quartile	II,III,IV	0.626	0.342	.008	28	view →
LUSC	OS	Tertile	All	0.847	0.722	.001	18	view →
BLCA	DFS	Median	IV	0.105	0.283	.015	14	view →
HNSC	DFS	Median	III,IV	0.759	0.622	.010	11	view →
UVM	OS	Tertile	III,IV	0.223	0.709	.045	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

JAKMIP2-AS1–MESO (DFS)

Open the MESO breakdown →